uMed is a company that specializes in building consented patient cohorts to accelerate research and generate insights that improve patient outcomes. Their ACCESS Research Platform is embedded across a global network of healthcare institutions, allowing researchers to access custom patient data from remote electronic health records, clinical outcomes, and patient-generated data. uMed collaborates with healthcare providers, life science researchers, and companies to address evidence gaps in research, improve treatment development, and make research more accessible. Their platform supports evidence collection and helps answer new research questions through deeply characterized patient data, ensuring privacy and transparency for all stakeholders involved.